Azenta, Inc. (AZTA) Stock

NASDAQ: AZTAProvides life sciences solutions, including sample management and genomic services.

Azenta stock price chart

AZTA stock quote & key statistics

Azenta earnings per share

Income →
Earnings per share

Azenta revenue & net income

Income →
RevenueNet income

Azenta annual financials

Income statement →
Azenta, Inc. revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$593.8M-$55.8M$0.53
FY2024$573.4M-$164.9M$0.41
FY2023$665.1M-$14.3M$0.32
FY2022$555.5M-$429.0M$0.52
FY2021$513.7M$110.7M$2.58

Fiscal year ending September 30. Source: company filings via EODHD.

About Azenta, Inc.

Azenta, Inc. offers comprehensive life science sample exploration and management solutions to the global life sciences market, including North America, Europe, China, and the Asia Pacific. The company operates through two main segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products segment provides automated cold sample management systems for storing compounds and biological samples, as well as equipment for sample preparation and handling. This segment also offers consumables and instruments designed to help customers manage samples throughout their research, discovery, and development processes.

The Life Sciences Services segment delivers a wide range of services to support scientific research and drug development. These services include comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services. Key offerings in this segment are sample storage, genomic sequencing, gene synthesis, laboratory processing and analysis, and biospecimen procurement. By offering these services, Azenta supports pharmaceutical companies, biotechnology firms, biorepositories, and research institutes in advancing their scientific endeavors.

Formerly known as Brooks Automation, Inc., the company rebranded to Azenta, Inc. in December 2021 to better reflect its focus on life sciences. Founded in 1978, Azenta has a long history of innovation and adaptation, continually evolving to meet the needs of the life sciences community. Headquartered in Chelmsford, Massachusetts, the company leverages decades of experience to provide cutting-edge solutions for sample management and research support.

Azenta, Inc. is dedicated to enhancing the efficiency and effectiveness of scientific research and development through its innovative products and services. With a global presence and a commitment to excellence, Azenta strives to empower life science customers to achieve breakthroughs in research and drug development, ultimately contributing to the advancement of human health and well-being.

Azenta stock FAQ

What is the Azenta stock ticker symbol?

Azenta, Inc. trades on the NASDAQ under the ticker symbol AZTA.

What sector and industry is Azenta in?

Azenta, Inc. is classified in the Healthcare sector, Medical Instruments & Supplies industry.

How many employees does Azenta have?

Azenta, Inc. has about 2,900 full-time employees.

What were Azenta's revenue and earnings last fiscal year?

Azenta reported revenue of $593.8M and net income of -$55.8M in fiscal 2025, with earnings per share of $0.53. Revenue grew 3.6% from the prior year.

Is Azenta in the S&P SmallCap 600?

Yes. Azenta, Inc. (AZTA) is a component of the S&P SmallCap 600, the benchmark index of profitable U.S. small-cap stocks.

Is Azenta in the Russell 2000?

Yes. Azenta, Inc. (AZTA) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did Azenta go public?

Azenta stock began trading on February 2, 1995.

S&P SmallCap 600 Healthcare stocks

All S&P SmallCap 600 →